Saira Kainat Suqaina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saira Kainat Suqaina has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Mavra Irfan
Cell and Molecular Biology Lab, Institute of Zoology, University of the Punjab, Lahore, Pakistan
3 shared publications - Nadeem Sheikh
Institute of Zoology University of the Punjab Quaid-i-Azam Campus 54590 Lahore Pakistan
3 shared publications - Tayyaba Saleem
Cell and Molecular Biology Lab, Institute of Zoology, University of the Punjab, Lahore, Pakistan
3 shared publications - Maryam Mukhtar
Cell and Molecular Biology Lab, Department of Zoology, University of the Punjab, Lahore, Pakistan
2 shared publications - Andleeb Batool
Department of Zoology, Government College University, Lahore, Pakistan
1 shared publication - Arooj Mustafa
Cell and Molecular Biology Laboratory, Department of Zoology, University of the Punjab, Lahore 54590, Pakistan
1 shared publication
Latest Publications
- Open Access
- 20 September 2022
- Published by Hindawi Limited in Genetics Research
- Vol. 2022, 1-11
TLR-8, TNF-α, and ESR-1α Gene Polymorphism Susceptibility in Onset of Arthritis
TLR-8, TNF-α, and ESR-1α Gene Polymorphism Susceptibility in Onset of Arthritis: Arthritis is a genetic disorder characterized by bones and joint degradation assisted by severe pain and inflammation. It is evident by the studies that 0 candidate genes variations play vital role in its development and progression. Therefore, we investigated the genetic variation of TLR-8, TNF, and ESR-1α genes in the Pakistani population. A case-control study comprising 300 RA, 316 OA, and 412 control subjects was conducted. PCR-RFLP and direct sequencing methods were used for determining genetic variations. Analysis was performed by using PLINK and MEGA 6.0 software. Allelic and genetic frequencies of polymorphisms identified on rs3764879 (TLR-8), rs3764880 (TLR-8), rs5744080 (TLR-8), rs1800629 (TNF), rs2228480 (ESR-1α), and rs1451501590 (ESR-1α) were significantly varied among RA, OA, and controls. Novel functional mutations SCV000844945 and SCV000844946 on TLR-8 as well as a non-functional SCV000804801 and functional variation SCV000804802 on ESR-1α were also identified and reported for the first time in the studied population. Multiple site analyses indicated that polymorphisms on TLR-8 and ESR-1α genes were significant risk factors in disease onset to the next generation. In conclusion, TLR-08 and ESR-1α were significant in the onset of arthritis whereas the TNF was not found as a significant risk factor in the onset of RA and OA.
- 20 September 2022
- Published by Hindawi Limited in Genetics Research
- Vol. 2022, 1-11
Open AccessTLR-8, TNF-α, and ESR-1α Gene Polymorphism Susceptibility in Onset of Arthritis
TLR-8, TNF-α, and ESR-1α Gene Polymorphism Susceptibility in Onset of Arthritis: Arthritis is a genetic disorder characterized by bones and joint degradation assisted by severe pain and inflammation. It is evident by the studies that 0 candidate genes variations play vital role in its development and progression. Therefore, we investigated the genetic variation of TLR-8, TNF, and ESR-1α genes in the Pakistani population. A case-control study comprising 300 RA, 316 OA, and 412 control subjects was conducted. PCR-RFLP and direct sequencing methods were used for determining genetic variations. Analysis was performed by using PLINK and MEGA 6.0 software. Allelic and genetic frequencies of polymorphisms identified on rs3764879 (TLR-8), rs3764880 (TLR-8), rs5744080 (TLR-8), rs1800629 (TNF), rs2228480 (ESR-1α), and rs1451501590 (ESR-1α) were significantly varied among RA, OA, and controls. Novel functional mutations SCV000844945 and SCV000844946 on TLR-8 as well as a non-functional SCV000804801 and functional variation SCV000804802 on ESR-1α were also identified and reported for the first time in the studied population. Multiple site analyses indicated that polymorphisms on TLR-8 and ESR-1α genes were significant risk factors in disease onset to the next generation. In conclusion, TLR-08 and ESR-1α were significant in the onset of arthritis whereas the TNF was not found as a significant risk factor in the onset of RA and OA.
- Open Access
- 28 June 2022
- Published by Albus Scientific Inc. in Albus Scientia
- Vol. 2022 (1)
A Synonymous Variant, GABRG2 rs211037 might be a Predictive Genetic Marker of Migraine: A Case Control Study from Pakistan
Background: Migraine is a severe neurovascular disease with some temporary symptoms like unilateral headache attacks associated with sensory and autonomic disturbances. It affects 12% of the general population worldwide. Females are more susceptible to migraine than males. The genetic and environmental factors contribute as a causative agent to its symptomatology. Gamma-aminobutyric acid (GABA) neurotransmitter plays a potential role in migraine pathophysiology that prompted us to evaluate the association between gamma-aminobutyric acid type a receptor gamma two subunit gene (GABRG2) polymorphisms and the risk of a migraine attack. Methods The present case-control study included 220 subjects (100 control; 120 patients). Blood samples were taken from all the participants and DNA was isolated. The selected SNPs (rs211037, rs121909672, and T813C) of exons 5, 7, and 8 of the GABRG2 gene were genotyped for cases and controls. Results: A silent polymorphism was found at the rs211037 polymorphic site, while no variation was found on other targeted sites either in the case or control population. Statistical analysis indicated significant differences in genotypic (p=<0.05) and allelic frequencies (p = <0.001; OR 2.039; 95% CI 1.346-3.089) and for dominant model (p = <0.001; OR 2.836; 95% CI 1.618-4.970). Conclusion: The result of our study showed that rs211037 polymorphism of the GABRG2 gene was significantly associated with migraines in the Pakistani population.
- 28 June 2022
- Published by Albus Scientific Inc. in Albus Scientia
- Vol. 2022 (1)
Open AccessA Synonymous Variant, GABRG2 rs211037 might be a Predictive Genetic Marker of Migraine: A Case Control Study from Pakistan
Background: Migraine is a severe neurovascular disease with some temporary symptoms like unilateral headache attacks associated with sensory and autonomic disturbances. It affects 12% of the general population worldwide. Females are more susceptible to migraine than males. The genetic and environmental factors contribute as a causative agent to its symptomatology. Gamma-aminobutyric acid (GABA) neurotransmitter plays a potential role in migraine pathophysiology that prompted us to evaluate the association between gamma-aminobutyric acid type a receptor gamma two subunit gene (GABRG2) polymorphisms and the risk of a migraine attack. Methods The present case-control study included 220 subjects (100 control; 120 patients). Blood samples were taken from all the participants and DNA was isolated. The selected SNPs (rs211037, rs121909672, and T813C) of exons 5, 7, and 8 of the GABRG2 gene were genotyped for cases and controls. Results: A silent polymorphism was found at the rs211037 polymorphic site, while no variation was found on other targeted sites either in the case or control population. Statistical analysis indicated significant differences in genotypic (p=<0.05) and allelic frequencies (p = <0.001; OR 2.039; 95% CI 1.346-3.089) and for dominant model (p = <0.001; OR 2.836; 95% CI 1.618-4.970). Conclusion: The result of our study showed that rs211037 polymorphism of the GABRG2 gene was significantly associated with migraines in the Pakistani population.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Mutational Analysis of Myoclonin1 Gene in Pakistani Juvenile Myoclonic Epilepsy Patients
Juvenile myoclonic epilepsy (JME) is the most prevalent and genetically heterogeneous form of epilepsy and accounts for 10–30% of all the cases worldwide. Ef‐hand domain‐ (c‐terminal‐) containing protein 1 (EFHC1) encodes for a nonion channel protein and mutations in this gene have been extensively reported in different populations to play a causative role in JME. Linkage between JME and 6p11‐12 locus has already been confirmed in Mexican and Dutch families. A case‐control study was conducted on Pakistani JME patients for the first time, aimed at finding out EFHC1 mutations that have been reported in different populations. For this purpose, 66 clinically diagnosed JME patients and 108 control subjects were included in the study. Blood samples were collected from all the participants, and DNA was isolated from the lymphocytes by the modified organic method. Total 3 exons of EFHC1, harboring extensively reported mutations, were selected for genotypic analysis. We identified three heterozygous variants, R159W, V460A, P436P, and one insertion in the current study. V460A, an uncommon variant identified herein, has recently been reported in public databases in an unphenotyped American individual. This missense variant was found in 3 Pakistani JME patients from 2 unrelated families. However, in silico analysis showed that V460A may possibly be a neutral variant. While the absence of a majority of previously reported mutations in our population suggests that most of the mutations of EFHC1 are confined to particular ethnicities and are not evenly distributed across the world. However, to imply the causation, the whole gene and larger number of JME patients should be screened in this understudied population.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Open AccessMutational Analysis of Myoclonin1 Gene in Pakistani Juvenile Myoclonic Epilepsy Patients
Juvenile myoclonic epilepsy (JME) is the most prevalent and genetically heterogeneous form of epilepsy and accounts for 10–30% of all the cases worldwide. Ef‐hand domain‐ (c‐terminal‐) containing protein 1 (EFHC1) encodes for a nonion channel protein and mutations in this gene have been extensively reported in different populations to play a causative role in JME. Linkage between JME and 6p11‐12 locus has already been confirmed in Mexican and Dutch families. A case‐control study was conducted on Pakistani JME patients for the first time, aimed at finding out EFHC1 mutations that have been reported in different populations. For this purpose, 66 clinically diagnosed JME patients and 108 control subjects were included in the study. Blood samples were collected from all the participants, and DNA was isolated from the lymphocytes by the modified organic method. Total 3 exons of EFHC1, harboring extensively reported mutations, were selected for genotypic analysis. We identified three heterozygous variants, R159W, V460A, P436P, and one insertion in the current study. V460A, an uncommon variant identified herein, has recently been reported in public databases in an unphenotyped American individual. This missense variant was found in 3 Pakistani JME patients from 2 unrelated families. However, in silico analysis showed that V460A may possibly be a neutral variant. While the absence of a majority of previously reported mutations in our population suggests that most of the mutations of EFHC1 are confined to particular ethnicities and are not evenly distributed across the world. However, to imply the causation, the whole gene and larger number of JME patients should be screened in this understudied population.